# OnCo record ascendis-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ascendis-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ascendis-pharma" ;
  schema:name "Ascendis Pharma"@en ;
  schema:alternateName "Ascendis Pharma A/S"@en, "Ascendis Pharma Oncology Division A/S"@en, "Ascendis Pharma Endocrinology Division A/S"@en ;
  schema:description "A Danish company with a long-acting growth hormone medicine approved in Europe, which also runs cancer trials of a long-acting form of the immune signal interleukin-2."@en ;
  schema:url <https://onco.cc/companies/ascendis-pharma/>, <https://ascendispharma.com/> ;
  schema:dateModified "2026-11-19"^^xsd:date ;
  schema:citation <https://ascendispharma.com/>, <https://ascendispharma.com/contact-us/>, <https://clinicaltrials.gov/study/NCT05081609>, <https://clinicaltrials.gov/study/NCT04799054>, <https://www.ema.europa.eu/en/medicines/human/EPAR/skytrofa> ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> ;
  onco:trials <https://onco.cc/trials/nct05081609/> .
